Effects of Semelil (ANGIPARS™) on focal cerebral ischemia in male rats

DARU, Journal of Pharmaceutical Sciences

Volumn 18, Issue 4, 2010, Pages 265-269

  Asadi Shekaari, M ^a   Eftekhar Vaghefi, H ^b   Talakoub, A ^a   Khorram Khorshid, H R ^c  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

Author keywords

Hippocampus; Middle cerebral artery (mcao); Re perfusion

Indexed keywords

ANGIPARS; HERBACEOUS AGENT; SEMELIL; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; FOCAL BRAIN ISCHEMIA; HERBAL MEDICINE; HIPPOCAMPUS; MALE; MIDDLE CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; RAT; SHAM PROCEDURE; TREATMENT RESPONSE;

EID: 79251510863     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hosseinzadeh H, Jaafari MR, Khoei AR, Rahmani M, Anti-ischemic Effect of Nigella sativa L. Seed in Male Rats, IJPR, 2006; 5, 53-58.
2. Hong JT, Ryu SR, Kim HJ, Lee JK. Protectiveeffectofgreenteaextractonischemia/reperfusion-inducedProtective effect of green tea extract on ischemia/induced brain injury in Mongolian gerbils. Brain Res, 2001; 888: 11-18.
3. Panahi M, Asadi Shekaari M, Kalantaripour TP, Safavi A. Aqueous extract of date fruit protectes CA1 neurons against oxidative injury: an ultrastructural study. Curr Topics in Nutraceutical Res, 2008; 6: 125-130.
4. Abdollahi M, Farzamfar B, Salari P, Khorram Khorshid HR, Larijani B, Farhadi M, Madani SH, Evaluation of acute and sub-chronic toxicity of Semelil (ANGIPARS™), a new phytotherapeutic drug for wound healing in rodents, DARU, 2008; 16, (Suppl 1), 7-14.
5. Farzamfar B, Abdollahi M, Ka'abinejadian S, Heshmat R, Shahhosseiny MH, Novitsky Y.A, Farhadi M. Sub-chronic toxicity study of a novel herbal-based formulation (Semelil) on dogs. DARU 2008; 16 (suppl 1): 15-19.
6. Khorram Khorshid HR, Sadeghi B, Heshmat R, Abdollahi M, Salari P, Farzamfar B, Madani SH, In vivo and in vitro genotoxicity studies of Semelil (ANGIPARSTM), DARU, 2008; 16, (Suppl 1), 20-24.
7. Consoli A. Chronic venous insufficiency: an open trial of FLEBS Crema. Minerva Cardioangiol 2003; 51:411-6.
8. Pleşca-Manea L, Pârvu AE, Pârvu M, Taǎmaş M, Buia R, Puia M. Effects of Melilotus officinalis on acute inflammation. Phytother Res 2002; 16:316-319.
9. Vettorello G, Cerreta G, Derwish A, Cataldi A, Schettino A, Occhionorelli S, Donini I. ContributionContribution of a combination of alpha and beta benzopyrones, flavonoids and natural terpenes in the treatment of lymphedema of the lower limbs at the 2nd stage of the surgical classification. Minerva Cardioangiol, 1996; 44:447-455.
10. Podkolzin AA, Dontsov VI, Sychev IA, Kobeleva GIu, Kharchenko ON. Immunocorrecting, antianemia, and adaptogenic effects of polysaccharides from Melilotus officinalisofficinalis. Biull Eksp Biol Med, 1996; 121:661-663.
11. Heshmat R, Mohammad K, Mohajeri Tehrani MR, Tabatabaie Malazy O, Keshtkar AA, GharibdoustF,Gharibdoust F, Larijani B. Assessment of maximum tolerated dose of a new herbal drug, Semelil (ANGIPARSTM) in patients with diabetic foot ulcer: a phase I clinical trial. DARU, 2008; 16: 25-30.
12. Larijani B, Heshmat R, Bahrami A, Delshad H, Ranjbar Omrani G, Mohammad K, Heidarpour R, Mohajeri Tehrani MR, Kamali K, Farhadi M, Gharibdoust F, Madani SH. Effects of Intravenous Semelil (ANGIPARSTM) on Diabetic Foot Ulcers Healing: A Multicenter Clinical Trial. DARU, 2008; 16(suppl.1): 35-40.
13. Shamimi-Nouri K, Karimian R, Nasli E, Kamali K, Chaman R, Farhadi M, Madani SH, Larijani B, Khorram Khorshid HR. Topical application of Semelil (ANGIPARSTM) in treatment of pressure ulcers: a randomized clinical trial. DARU, 2008; 16: 54- 57.
14. Hirakawa T, Okawa M, Kinjo J, Nohara T. A new oleanene glucuronide obtained from the aerial parts of Melilotus officinalis. Chem Pharm Bull (Tokyo) 2000; 48:286-287.
15. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniotomy in rats. Stroke, 1989; 20:84-91.
16. Sakurai-Yamashita Y, Kinugawa H, Niwa M. Neuroprotective effect of Pentosan polysulphate on ischemia-related neuronal death of hippocampus. Neurosci Lett, 2006; 409:30-34.
17. Li Y, Chopp M, Jiang N, Zhang ZG, Zaloga C. Induction of DNA fragmentation after 10 to 120 minutes of focal cerebral ischemia in rats. Stroke, 1995; 26:1252-1258.
18. Golubouff B, Shenkin HA, Haft H. The effects of manitol and Urea on cerebral hemodynamics and cerebrospinal fluid pressure. Neurology, 1964; 14: 891-899.
19. Gupta R, Singh M, Sharma A. Neuroprotective effect of antioxidants on ischaemia and reperfusion-induced cerebral injury. Pharmacological Res, 2003; 209-215.
20. Rayssiguier Y, Gueux E, Nowacki W, Rock E, Mazur A. High fructose consumption combined with low dietary magnesium intake may increase the incidence of the metabolic syndrome by inducing inflammation. Magnesium Res, 2006; 19: 4, 237-243.
21. Huang Y, McNamara JO. Ischemic stroke: "acidotoxicity" is a perpetrator. Cell, 2004; 118:665-666.
22. Durukan A, Tatlisumak T. Acute ischemic stroke: Overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol, biochem and behave, 2007; 87: 179-197.